Tuesday, 11 November 2014

R&I: DNA diagnostic would increase significantly in Asia-Pacific

The DNA method is extremely useful to diagnose numerous diseases such as infectious diseases, myogenic disorders, and various forms of cancer. Indeed, the DNA diagnostics procedure has brought revolutionary changes to keep a tab on human health. The importance of DNA increases as the threat from various viruses are erupting globally.

As per the report published by AMR, the DNA diagnostic market would have a value of $19 billion by 2020 with a CAGR of 9.8% during the forecast period. This prediction is made in a report titled “Global DNA Diagnostics Market (Applications, Technology and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 – 2020.”

Next generation sequencing, which is a part of advanced DNA sequencing helps to diagnose chronic disorders such as HIV and Cancer. With the increase of such disease, the global DNA diagnostics market would experience a significant growth rate in the future. Rise in technologies such as polymerase chain reaction (PCR), microarray, sequencing technology, mass spectrometry technology and in situ hybridization would further propel the market growth.

"While Next generation sequencing has had a significant impact on the diagnostic procedures and is set to gain momentum in the foreseeable future,” states AMR analyst Sharayu Dhabale. "Next generation sequencing not only reduces the cost of sequencing, but increases the throughput as well; it could thus help in bridging the gaps in traditional and personalized medications", adds the analyst.
North America and Europe would hold a dominant share in the global market. However with rising healthcare expenditure, Asia Pacific is expected to witness an increasing growth during the forecast period.

Key companies profiled in the report are:-
·         Bayer Diagnostic
·         Sysmex
·         Roche Diagnostics
·         Abbott laboratories
·         Cephide, Gene-probe Inc.
·         Illumina, Inc
·         Thermo Fisher Scientific
·         Bio-Rad Laboratories
·         Johnson and Johnson, and
·         Novartis.

No comments:

Post a Comment